West Pharmaceutical Services, Inc., a global developer and manufacturer of components and systems for injectable drug delivery, announced the expansion of the NovaGuard portfolio of needle safety products.
The NovaGuard SA (Staked-needle Automatic) system, formerly called the B.Safe syringe system technology, is now part of the NovaGuard system technology platform of syringe safety systems with needlestick prevention features. The NovaGuard SA system technology reduces the risk of needlestick injuries around staked-needle prefilled syringe systems. Prospective customers began evaluating NovaGuard SA last year, and West is expanding capacity to meet expected increases in market demand.
West works with top pharmaceutical and biotechnology companies to design and manufacture drug packaging and delivery systems that bring injectable drugs from concept to the patient efficiently, reliably, and safely.
The NovaGuard products platform brings several of West’s leading drug delivery and needle safety technologies together under a unified brand aimed at enhancing the safety, convenience, and effectiveness of drug administration, and will complement West’s packaging and delivery solutions for drugs packaged in a prefillable syringe.
“Accidental needlestick injuries are a major cause of exposure to serious diseases among healthcare workers, with more than one million needlestick injuries occurring each year,” said Ron Stoker, executive director, International Sharps Injury Prevention Society. “We believe that a significant number of needlestick injuries can be prevented by adopting safety-engineered products and services. Innovative technologies such as West’s NovaGuard safety systems are vital to reducing the risk of life-threatening needlestick injuries and play a key role in keeping both healthcare workers and patients safe.”
